GO:0070002 glutamic-type peptidase activity

GO:0070002 glutamic-type peptidase activity is a molecular function ontology term that defines catalysis of peptide bond hydrolysis via a glutamate/glutamine catalytic dyad. Unlike the well-known serine, cysteine, aspartate and metalloprotease classes, this mechanism relies on a glutamate or glutamine residue acting as the catalytic nucleophile or general base within the active site. The term is therefore used to annotate proteases whose catalytic chemistry does not fit the classical protease classification schemes. In experimental biology, glutamic-type peptidase activity is most frequently studied in the context of plasminogen activation, where glutamic-plasminogen (Glu-plasminogen) is converted to plasmin by tissue plasminogen activator (tPA) or urokinase [1,2,3]. This conversion is a critical step in fibrinolysis and is modulated by cofactors such as fucoidan, heparin and cyanogen bromide-fibrinogen digest [1,2]. Because dysregulated proteolysis contributes to thrombosis, cancer invasion and inflammatory disorders, understanding glutamic-type peptidase activity has direct translational relevance [1,3]. The term also matters for genome annotation: correct assignment of GO:0070002 ensures that proteases with a glutamate/glutamine dyad are distinguished from other peptidase families in functional enrichment and pathway analyses. For researchers using CRISPR screens or knockout models, GO:0070002 provides a functional handle to prioritize candidate genes involved in plasminogen activation and related proteolytic cascades [1,2,3].

In our own words, GO:0070002 glutamic-type peptidase activity refers to the catalytic function of an enzyme that cleaves peptide bonds in a polypeptide chain using a glutamate or glutamine residue as part of a catalytic dyad. This mechanism is distinct from serine, cysteine, aspartate and metallopeptidase mechanisms because the catalytic machinery is built around a glutamate/glutamine pair rather than a serine-histidine-aspartate triad, a cysteine-histidine dyad, or a metal ion. The term is a molecular_function annotation and is applied to proteases that hydrolyze peptide substrates through this specific chemical strategy. In practice, the best-characterized context for this activity is the activation of glutamic-plasminogen by tissue plasminogen activator and urokinase, where the glutamate/glutamine dyad contributes to the catalytic cycle [1,2,3]. The QuickGO definition emphasizes that the hydrolysis occurs in a polypeptide chain, meaning the substrate is a protein or peptide rather than a small-molecule ester. Because the definition is mechanism-based, it can be applied across species and protein families as long as the glutamate/glutamine dyad is the catalytic core.

GO:0070002 glutamic-type peptidase activity is important because it defines a mechanistically distinct class of proteolytic enzymes that cannot be captured by classical protease annotations. The term is central to understanding plasminogen activation, a process that governs clot dissolution and is modulated by physiologically relevant cofactors such as fucoidan, heparin and cyanogen bromide-fibrinogen digest [1,2]. Because urokinase-mediated activation of glutamic-plasminogen is sensitive to sodium chloride concentration, the activity is also a model for studying how ionic strength and cofactor binding regulate protease function. In biomedical research, accurate annotation of GO:0070002 supports functional genomics, CRISPR screening and drug discovery efforts aimed at thrombolytic or anti-proteolytic therapies [1,2,3]. The term also helps distinguish glutamic-type peptidases from other peptidase classes in enrichment analyses, reducing false assignments in pathway and network studies.

The following genes and proteins are directly implicated in glutamic-type peptidase activity and its best-characterized context, the activation of glutamic-plasminogen.

Glutamic-type peptidase activity is regulated at multiple levels. Cofactors such as fucoidan, heparin and cyanogen bromide-fibrinogen digest enhance the activation of human glutamic-plasminogen by tissue plasminogen activator, indicating positive regulation by polyanionic and peptide cofactors [1,2]. Sodium chloride concentration modulates urokinase-mediated activation of glutamic-plasminogen, showing that ionic strength is a regulatory parameter. In physiological settings, plasminogen activator inhibitors such as SERPINE1 and SERPINB2 provide negative regulation of the activators that drive this activity. The interplay between activators, inhibitors and cofactors determines the net rate of plasmin generation and thus the functional output of glutamic-type peptidase activity [1,2,3].

Glutamic-type peptidase activity is central to the activation of glutamic-plasminogen, the precursor of plasmin, which degrades fibrin clots [1,2]. When this activity is insufficient or improperly regulated, fibrin accumulates and thrombotic risk increases. Cofactors such as fucoidan and heparin enhance Glu-plasminogen activation, which is the rationale for using heparin-like molecules in anticoagulant and thrombolytic strategies [1,3]. Sodium chloride sensitivity of urokinase-mediated activation further links the activity to the ionic environment of plasma.

Plasmin generated through glutamic-type peptidase activity can degrade extracellular matrix components, a process implicated in tumor invasion and metastasis. Urokinase-mediated activation of Glu-plasminogen is particularly relevant to pericellular proteolysis in cancer. Because fucoidan and CNBr-fibrinogen digest modulate this activation, the tumor microenvironment may influence the efficiency of plasmin generation [1,2]. Targeting this activity is therefore of interest in oncology research [1,3].

Dysregulated plasminogen activation contributes to inflammatory and vascular pathologies through excessive proteolysis. The modulation of glutamic-type peptidase activity by heparin and related polyanions connects it to inflammatory pathways in which glycosaminoglycans are abundant [1,3]. Understanding how cofactors and ionic conditions regulate this activity may inform therapeutic approaches for inflammatory vascular disease [2,3].

The most direct way to study glutamic-type peptidase activity is to incubate Glu-plasminogen with tissue plasminogen activator or urokinase and measure plasmin generation over time [1,2,3]. These assays can be performed with chromogenic or fluorogenic substrates and are sensitive to cofactors such as fucoidan, heparin and CNBr-fibrinogen digest [1,2]. Sodium chloride concentration can be varied to assess ionic regulation of urokinase-mediated activation.

Kinetic experiments determine the rate of peptide bond hydrolysis as a function of substrate and cofactor concentration [1,2]. Titrating fucoidan, heparin or CNBr-fibrinogen digest reveals whether these molecules act as enhancers or inhibitors of glutamic-type peptidase activity [1,2]. Such experiments provide mechanistic insight into the glutamate/glutamine dyad mechanism.

CRISPR knockout and knock-in screens can identify genes that regulate glutamic-type peptidase activity in cells [1,2,3]. By coupling plasminogen activation to a selectable or fluorescent reporter, researchers can screen libraries for modifiers of this activity. Point mutations in candidate catalytic residues can be introduced to test whether a gene product uses a glutamate/glutamine dyad.

Mass spectrometry-based proteomics can identify cleavage products generated by glutamic-type peptidases, providing a global view of substrate specificity. Comparing wild-type and knockout cells reveals substrates whose processing depends on this activity [1,2]. Such profiling complements targeted plasminogen activation assays [1,3].

Researchers studying glutamic-type peptidase activity-related genes often need to determine whether a candidate gene is causally involved in peptide bond hydrolysis or in the regulation of plasminogen activation. EDITGENE provides CRISPR-based cell model services that enable loss-of-function, gain-of-function and precise mutation studies for genes annotated to GO:0070002 and its associated pathways.

GO:0070002 glutamic-type peptidase activity defines a mechanistically distinct protease function built on a glutamate/glutamine catalytic dyad. Its best-characterized role is in the activation of glutamic-plasminogen by tissue plasminogen activator and urokinase, a process modulated by fucoidan, heparin, cyanogen bromide-fibrinogen digest and sodium chloride [1,2,3]. Accurate annotation and experimental study of this activity are important for fibrinolysis research, cancer biology and therapeutic development [1,3]. CRISPR-based cell models provide a powerful way to dissect the genes and mechanisms underlying this activity.